J.C. Hsu

Post Doctoral Fellow

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

3 h-index 11 pubs 32 cited

Research Areas

Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors Drug-Induced Hepatotoxicity and Protection Health and Medical Research Impacts Long-Term Effects of COVID-19 Health Literacy and Information Accessibility SARS-CoV-2 and COVID-19 Research

Links

Lab Website UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

J.C. Hsu's research focuses on the prevention of cardiotoxicity induced by the chemotherapy drug doxorubicin. His work investigates the role of dexrazoxane in mitigating this side effect, with a particular emphasis on its dose-response and time-course effects. Recent publications explore the degradation of topoisomerase 2b by dexrazoxane as a mechanism for preventing doxorubicin-induced cardiotoxicity in human subjects. Hsu has published 11 papers, with a total of 32 citations and an h-index of 3. He has collaborated with Edward T.H. Yeh and Hui‐Ming Chang at the University of Arkansas for Medical Sciences, co-authoring two publications with each.

Metrics

h-index: 3
Publications: 11
Citations: 32

Selected Publications

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b (2025) DOI
Abstract 12348: Targeted Degradation of Topoisomerase 2b by Dexrazoxane for Prevention of Doxorubicin-Induced Cardiotoxicity: Dose and Time Course Study in Human (2023) DOI